Top Clinical Trial Supplies Companies

Clinical Trial Supplies Market size was valued at USD 3.31 Billion in 2024 and is poised to grow from USD 3.54 Billion in 2025 to USD 6.03 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026–2033).

The key vendors in the Clinical Trial Supplies Market include Thermo Fisher Scientific Inc., Catalent, Inc., Parexel International Corporation, DHL Supply Chain, Marken (UPS Healthcare), PCI Pharma Services, Almac Group, Cencora, Inc., Sharp Services, LLC, and Eurofins Scientific. These companies provide clinical supply packaging, labeling, distribution, temperature-controlled logistics, and clinical trial management solutions.

The key driver of the Clinical Trial Supplies Market is the growing number of clinical trials worldwide, driven by increasing pharmaceutical and biotechnology research and development investments. Rising demand for specialized medicines, biologics, temperature-controlled logistics, and reliable clinical supply chain management further supports market growth.

The key market trend in the Clinical Trial Supplies Market is the growing adoption of decentralized clinical trials and advanced supply chain technologies. Companies are increasingly using real-time inventory tracking, temperature-monitoring systems, direct-to-patient delivery, and digital supply management to improve efficiency, ensure product integrity, and streamline clinical trial operations.

North America accounted for the largest share of the Clinical Trial Supplies Market, driven by substantial pharmaceutical and biotechnology R&D investments, a strong clinical research infrastructure, and a high number of ongoing clinical trials. The presence of leading contract research organizations and specialized logistics providers further supports regional market dominance.